ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19 prnasia
April 15, 2020On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Lianhua Qing -
Linzess Approved in Japan for Additional Indication
americanpharmaceuticalreview
August 22, 2018Astellas Pharma and Ironwood Pharmaceuticals announced approval has been obtained in Japan for the guanylate cyclase-C receptor agonist Linzess Tablets 0.25 mg (linaclotide) for the additional indication of chronic constipation.
Pharma Sources Insight January 2025
